Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ.
<h4>Background</h4>Treatments for inflammatory bowel disease (IBD) are modestly effective and associated with side effects from prolonged use. As there is no known cure for IBD, alternative therapeutic options are needed. Peroxisome proliferator-activated receptor-gamma (PPARγ) has been...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/996adb1b59ca44dd899616e84480526d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:996adb1b59ca44dd899616e84480526d |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:996adb1b59ca44dd899616e84480526d2021-11-18T06:46:59ZDietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ.1932-620310.1371/journal.pone.0024031https://doaj.org/article/996adb1b59ca44dd899616e84480526d2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21904603/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Treatments for inflammatory bowel disease (IBD) are modestly effective and associated with side effects from prolonged use. As there is no known cure for IBD, alternative therapeutic options are needed. Peroxisome proliferator-activated receptor-gamma (PPARγ) has been identified as a potential target for novel therapeutics against IBD. For this project, compounds were screened to identify naturally occurring PPARγ agonists as a means to identify novel anti-inflammatory therapeutics for experimental assessment of efficacy.<h4>Methodology/principal findings</h4>Here we provide complementary computational and experimental methods to efficiently screen for PPARγ agonists and demonstrate amelioration of experimental IBD in mice, respectively. Computational docking as part of virtual screening (VS) was used to test binding between a total of eighty-one compounds and PPARγ. The test compounds included known agonists, known inactive compounds, derivatives and stereoisomers of known agonists with unknown activity, and conjugated trienes. The compound identified through VS as possessing the most favorable docked pose was used as the test compound for experimental work. With our combined methods, we have identified α-eleostearic acid (ESA) as a natural PPARγ agonist. Results of ligand-binding assays complemented the screening prediction. In addition, ESA decreased macrophage infiltration and significantly impeded the progression of IBD-related phenotypes through both PPARγ-dependent and -independent mechanisms in mice with experimental IBD.<h4>Conclusions/significance</h4>This study serves as the first significant step toward a large-scale VS protocol for natural PPARγ agonist screening that includes a massively diverse ligand library and structures that represent multiple known target pharmacophores.Stephanie N LewisLera BrannanAmir J GuriPinyi LuRaquel HontecillasJosep Bassaganya-RieraDavid R BevanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e24031 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Stephanie N Lewis Lera Brannan Amir J Guri Pinyi Lu Raquel Hontecillas Josep Bassaganya-Riera David R Bevan Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ. |
| description |
<h4>Background</h4>Treatments for inflammatory bowel disease (IBD) are modestly effective and associated with side effects from prolonged use. As there is no known cure for IBD, alternative therapeutic options are needed. Peroxisome proliferator-activated receptor-gamma (PPARγ) has been identified as a potential target for novel therapeutics against IBD. For this project, compounds were screened to identify naturally occurring PPARγ agonists as a means to identify novel anti-inflammatory therapeutics for experimental assessment of efficacy.<h4>Methodology/principal findings</h4>Here we provide complementary computational and experimental methods to efficiently screen for PPARγ agonists and demonstrate amelioration of experimental IBD in mice, respectively. Computational docking as part of virtual screening (VS) was used to test binding between a total of eighty-one compounds and PPARγ. The test compounds included known agonists, known inactive compounds, derivatives and stereoisomers of known agonists with unknown activity, and conjugated trienes. The compound identified through VS as possessing the most favorable docked pose was used as the test compound for experimental work. With our combined methods, we have identified α-eleostearic acid (ESA) as a natural PPARγ agonist. Results of ligand-binding assays complemented the screening prediction. In addition, ESA decreased macrophage infiltration and significantly impeded the progression of IBD-related phenotypes through both PPARγ-dependent and -independent mechanisms in mice with experimental IBD.<h4>Conclusions/significance</h4>This study serves as the first significant step toward a large-scale VS protocol for natural PPARγ agonist screening that includes a massively diverse ligand library and structures that represent multiple known target pharmacophores. |
| format |
article |
| author |
Stephanie N Lewis Lera Brannan Amir J Guri Pinyi Lu Raquel Hontecillas Josep Bassaganya-Riera David R Bevan |
| author_facet |
Stephanie N Lewis Lera Brannan Amir J Guri Pinyi Lu Raquel Hontecillas Josep Bassaganya-Riera David R Bevan |
| author_sort |
Stephanie N Lewis |
| title |
Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ. |
| title_short |
Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ. |
| title_full |
Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ. |
| title_fullStr |
Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ. |
| title_full_unstemmed |
Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ. |
| title_sort |
dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/996adb1b59ca44dd899616e84480526d |
| work_keys_str_mv |
AT stephanienlewis dietaryaeleostearicacidamelioratesexperimentalinflammatoryboweldiseaseinmicebyactivatingperoxisomeproliferatoractivatedreceptorg AT lerabrannan dietaryaeleostearicacidamelioratesexperimentalinflammatoryboweldiseaseinmicebyactivatingperoxisomeproliferatoractivatedreceptorg AT amirjguri dietaryaeleostearicacidamelioratesexperimentalinflammatoryboweldiseaseinmicebyactivatingperoxisomeproliferatoractivatedreceptorg AT pinyilu dietaryaeleostearicacidamelioratesexperimentalinflammatoryboweldiseaseinmicebyactivatingperoxisomeproliferatoractivatedreceptorg AT raquelhontecillas dietaryaeleostearicacidamelioratesexperimentalinflammatoryboweldiseaseinmicebyactivatingperoxisomeproliferatoractivatedreceptorg AT josepbassaganyariera dietaryaeleostearicacidamelioratesexperimentalinflammatoryboweldiseaseinmicebyactivatingperoxisomeproliferatoractivatedreceptorg AT davidrbevan dietaryaeleostearicacidamelioratesexperimentalinflammatoryboweldiseaseinmicebyactivatingperoxisomeproliferatoractivatedreceptorg |
| _version_ |
1718424431631532032 |